Key player · Company profile
Sun Pharmaceutical Industries Ltd.
Named as a key player in 165 of our reports, across 33 regions and countries.
Named as a key player in 165 of our reports, across 33 regions and countries.
2023–2033 CAGR · estimates
Australia 5
Brazil 5
Canada 5
China 5
Ecuador 5
Egypt 5
France 5
Germany 5
Hong Kong 5
India 5
Italy 5
Japan 5
Kenya 5
Malaysia 5
Mexico 5
New Zealand 5
Philippines 5
Russia 5
Saudi Arabia 5
Singapore 5
South Africa 5
Spain 5
Thailand 5
UAE 5
UK 5
US 5| Market | Category | World 2023 | CAGR |
|---|---|---|---|
| Over The Counter (OTC) Analgesics | OTC & Nutraceuticals | $22 Bn | 3.4% |
| Alexipharmic Drugs | Pharmaceuticals | – | – |
| Alopecia areata | Healthcare Services | – | – |
| Alopecia Drugs (Hair Loss) | Pharmaceuticals | – | – |
| Anthelmintic Drug | OTC & Nutraceuticals | – | – |
Named as key players in the same markets as Sun Pharmaceutical Industries Ltd. (number of shared markets).
Novartis AG4 shared markets
AstraZeneca3 shared markets
Cipla Inc.3 shared markets
Johnson & Johnson3 shared markets
Merck & Co., Inc.3 shared markets
Sanofi3 shared markets
Bayer AG2 shared markets
Boehringer Ingelheim International GmbH2 shared markets
Search all reports for Sun Pharmaceutical Industries Ltd. All companies